Erratum: Regulation of Blood Pressure, Appetite, and Glucose by Leptin After Inactivation of Insulin Receptor Substrate 2 Signaling in the Entire Brain or in Proopiomelanocortin Neurons (Hypertension (2016) 67 (378-386) DOI: 10.1161/HYPERTENSIONAHA.115.06153);Regulation of Blood Pressure, Appetite, and Glucose by Leptin after Inactivation of Insulin Receptor Substrate 2 Signaling in the Entire Brain or in Proopiomelanocortin Neurons

Hypertension

Volumn 67, Issue 2, 2016, Pages 378-386

  Do Carmo, Jussara M ^a   Da Silva, Alexandre A ^a   Wang, Zhen ^a   Freeman, Nathan J ^a   Alsheik, Ammar J ^a   Adi, Ahmad ^a   Hall, John E ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Blood pressure; heart rate; insulin; obesity; proopiomelanocortin

Indexed keywords

CRE RECOMBINASE; GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE 2; LEPTIN; NESTIN; PROOPIOMELANOCORTIN; GLUCOSE BLOOD LEVEL; INSULIN RECEPTOR SUBSTRATE; IRS2 PROTEIN, MOUSE;

ACUTE STRESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; APPETITE; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY WEIGHT; BRAIN; BRAIN NERVE CELL; BREATHING RATE; CARDIOVASCULAR FUNCTION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; FOOD INTAKE; HEART RATE; INSULIN RESPONSE; INTRAVENOUS CATHETER; MALE; MEAN ARTERIAL PRESSURE; MOTOR ACTIVITY; MOUSE; NONHUMAN; OSCILLATION; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TELEMETRY; ANIMAL; BLOOD PRESSURE; DISEASE MODEL; DRUG EFFECTS; ENERGY METABOLISM; GLUCOSE BLOOD LEVEL; HYPERTENSION; METABOLISM; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; APPETITE; BLOOD GLUCOSE; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; HYPERTENSION; INSULIN RECEPTOR SUBSTRATE PROTEINS; LEPTIN; MALE; MICE; MICE, TRANSGENIC; NEURONS; PRO-OPIOMELANOCORTIN; SIGNAL TRANSDUCTION;

EID: 84954379006     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYP.0000000000000102     Document Type: Erratum

References (30)

1. Harris RB. Leptin-much more than a satiety signal. Annu Rev Nutr. 2000;20:45-75. doi: 10.1146/annurev.nutr.20.1.45.
2. Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell. 2001;104:531-543.
3. Bjørbaek C, Kahn BB. Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res. 2004;59:305-331.
4. Badman MK, Flier JS. The gut and energy balance: visceral allies in the obesity wars. Science. 2005;307:1909-1914. doi: 10.1126/science.1109951.
5. Münzberg H, Myers MG Jr. Molecular and anatomical determinants of central leptin resistance. Nat Neurosci. 2005;8:566-570. doi: 10.1038/nn1454.
6. Yang R, Barouch LA. Leptin signaling and obesity: cardiovascular consequences. Circ Res. 2007;101:545-559. doi: 10.1161/CIRCRESAHA.107.156596.
7. Hirashima Y, Tsuruzoe K, Kodama S, Igata M, Toyonaga T, Ueki K, Kahn CR, Araki E. Insulin down-regulates insulin receptor substrate-2 expression through the phosphatidylinositol 3-kinase/Akt pathway. J Endocrinol. 2003;179:253-266.
8. Udelhoven M, Pasieka M, Leeser U, Krone W, Schubert M. Neuronal insulin receptor substrate 2 (IRS2) expression is regulated by ZBP89 and SP1 binding to the IRS2 promoter. J Endocrinol. 2010;204:199-208. doi: 10.1677/JOE-09-0266.
9. Morrison CD, Morton GJ, Niswender KD, Gelling RW, Schwartz MW. Leptin inhibits hypothalamic Npy and Agrp gene expression via a mechanism that requires phosphatidylinositol 3-OH-kinase signaling. Am J Physiol Endocrinol Metab. 2005;289:E1051-E1057. doi: 10.1152/ajpendo.00094.2005.
10. Rahmouni K, Morgan DA, Morgan GM, Liu X, Sigmund CD, Mark AL, Haynes WG. Hypothalamic PI3K and MAPK differentially mediate regional sympathetic activation to insulin. J Clin Invest. 2004;114:652-658. doi: 10.1172/JCI21737.
11. Rahmouni K, Haynes WG, Morgan DA, Mark AL. Intracellular mechanisms involved in leptin regulation of sympathetic outflow. Hypertension. 2003;41(3 Pt 2):763-767. doi: 10.1161/01.HYP.0000048342.54392.40.
12. Kubota N, Tobe K, Terauchi Y, et al. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes. 2000;49:1880-1889.
13. Tallam LS, da Silva AA, Hall JE. Melanocortin-4 receptor mediates chronic cardiovascular and metabolic actions of leptin. Hypertension. 2006;48:58-64. doi: 10.1161/01.HYP.0000227966.36744.d9.
14. do Carmo JM, da Silva AA, Cai Z, Lin S, Dubinion JH, Hall JE. Control of blood pressure, appetite, and glucose by leptin in mice lacking leptin receptors in proopiomelanocortin neurons. Hypertension. 2011;57:918-926. doi: 10.1161/HYPERTENSIONAHA.110.161349.
15. Dubois NC, Hofmann D, Kaloulis K, Bishop JM, Trumpp A. Nestin-Cre transgenic mouse line Nes-Cre1 mediates highly efficient Cre/loxP mediated recombination in the nervous system, kidney, and somite-derived tissues. Genesis. 2006;44:355-360. doi: 10.1002/dvg.20226.
16. Masaki T, Chiba S, Noguchi H, Yasuda T, Tobe K, Suzuki R, Kadowaki T, Yoshimatsu H. Obesity in insulin receptor substrate-2-deficient mice: disrupted control of arcuate nucleus neuropeptides. Obes Res. 2004;12:878-885. doi: 10.1038/oby.2004.106.
17. Choudhury AI, Heffron H, Smith MA, et al. The role of insulin receptor substrate 2 in hypothalamic and beta cell function. J Clin Invest. 2005;115:940-950. doi: 10.1172/JCI24445.
18. Padilla SL, Reef D, Zeltser LM. Defining POMC neurons using transgenic reagents: impact of transient Pomc expression in diverse immature neuronal populations. Endocrinology. 2012;153:1219-1231. doi: 10.1210/en.2011-1665.
19. Dubinion JH, do Carmo JM, Adi A, Hamza S, da Silva AA, Hall JE. Role of proopiomelanocortin neuron Stat3 in regulating arterial pressure and mediating the chronic effects of leptin. Hypertension. 2013;61:1066-1074. doi: 10.1161/HYPERTENSIONAHA.111.00020.
20. Sadagurski M, Leshan RL, Patterson C, Rozzo A, Kuznetsova A, Skorupski J, Jones JC, Depinho RA, Myers MG Jr, White MF. IRS2 signaling in LepR-b neurons suppresses FoxO1 to control energy balance independently of leptin action. Cell Metab. 2012;15:703-712. doi: 10.1016/j.cmet.2012.04.011.
21. da Silva AA, Tallam LS, Liu J, Hall JE. Chronic antidiabetic and cardiovascular actions of leptin: role of CNS and increased adrenergic activity. Am J Physiol Regul Integr Comp Physiol. 2006;291:R1275-R1282. doi: 10.1152/ajpregu.00187.2006.
22. do Carmo JM, Hall JE, da Silva AA. Chronic central leptin infusion restores cardiac sympathetic-vagal balance and baroreflex sensitivity in diabetic rats. Am J Physiol Heart Circ Physiol. 2008;295:H1974-H1981. doi: 10.1152/ajpheart.00265.2008.
23. do Carmo JM, da Silva AA, Dubinion J, Sessums PO, Ebaady SH, Wang Z, Hall JE. Control of metabolic and cardiovascular function by the leptin-brain melanocortin pathway. IUBMB Life. 2013;65:692-698. doi: 10.1002/iub.1187.
24. Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension. 1998;31(1 Pt 2):409-414.
25. Coppari R, Bjørbæk C. Leptin revisited: its mechanism of action and potential for treating diabetes. Nat Rev Drug Discov. 2012;11:692-708. doi: 10.1038/nrd3757.
26. Perry RJ, Zhang XM, Zhang D, Kumashiro N, Camporez JP, Cline GW, Rothman DL, Shulman GI. Leptin reverses diabetes by suppression of the hypothalamic-pituitary-adrenal axis. Nat Med. 2014;20:759-763. doi: 10.1038/nm.3579.
27. do Carmo JM, Tallam LS, Roberts JV, Brandon EL, Biglane J, da Silva AA, Hall JE. Impact of obesity on renal structure and function in the presence and absence of hypertension: evidence from melanocortin-4 receptor-deficient mice. Am J Physiol Regul Integr Comp Physiol. 2009;297:R803-R812. doi: 10.1152/ajpregu.00187.2009.
28. Elias CF, Lee C, Kelly J, Aschkenasi C, Ahima RS, Couceyro PR, Kuhar MJ, Saper CB, Elmquist JK. Leptin activates hypothalamic CART neurons projecting to the spinal cord. Neuron. 1998;21:1375-1385.
29. Elmquist JK, Ahima RS, Elias CF, Flier JS, Saper CB. Leptin activates distinct projections from the dorsomedial and ventromedial hypothalamic nuclei. Proc Natl Acad Sci USA. 1998;95:741-746.
30. do Carmo JM, da Silva AA, Sessums PO, Ebaady SH, Pace BR, Rushing JS, Davis MT, Hall JE. Role of Shp2 in forebrain neurons in regulating metabolic and cardiovascular functions and responses to leptin. Int J Obes (Lond). 2014;38:775-783. doi: 10.1038/ijo.2013.177.